Nearly 1.25 lakh Indians returned from overseas under Vande Bharat Mission: Hardeep Puri

New Delhi, Mar 20: The coronavirus pandemic will leave behind a global recession with small businesses, self-employed and daily wagers taking the worst hit, Mahindra Group Chairman Anand Mahindra said on thursday.

"The virus will eventually be conquered, but it will have left behind a global recession. The costs of that are incalculably high at this time. The most fearsome toll will be on small businesses, the self-employed & those whose lives depend on meagre daily wages," Mahindra said in a tweet.

Apart from the toll on lives, the legacy of Covid-19 may well be deaths due to stress, loss of livelihoods, a rise in homelessness and in extreme situations, civil unrest, he added.

"The only global experience that has lessons for us in the current situation is the last world war. In the aftermath of WW2, the US came up with the Marshall plan to revive Europe, effectively a giant fiscal pump-priming," Mahindra said.

In the US, the government dramatically dismantled regulations and opened up the economy to trade and these actions led to a boom-cycle that stretched to 1975, he added.

"This time, there will be no victors, only the vanquished. So every country will have to create its own post ‘virus war” marshall plan & take care of those in society who are hit the hardest. Perhaps we too can build the foundations of a sustained global growth cycle," Mahindra said.

New Delhi, Mar 7: Bhim Army chief Chandrashekhar Azad has taunted Bahujan Samaj Party chief Mayawati saying that she has lost her way. He also said that one will have to work for the larger interest of the society to bring about equality. Only the speeches cannot improve the condition of the Dalits, their participation in power must increase.

In an interview with media persons, Chandrashekhar said: "Members of minority community, Dalits and backward classes are being targeted in the country. Their rights are being taken away. Our workers want that they too should get equal share in political power. Keeping this in mind, we are going to form a new political party on March 15. Their (Dalits) issues will have to be raised. Mere speeches will not work for Bahujan society, one has to raise voice in their favour. They should get a share in power."

On the question that how he would find a foothold in view of large political base of the BSP, Chandrashekhar said, "We are not looking for an alternative. Look at the crores of Muslims, Dalits, members of backward community and minorities. We have to protect their interests. We have a large organisation in the state. Our Bharat Bandh was also successful".

On the question that with which party he will forge an alliance in 2022 after forming his party on March 15, Chandrashekhar said: "When we are forming our party then we don't need to go seeking alliance with anyone. Our party will be formed on the basis of some principles. Whoever will find it suitable will come close to us".

On meeting with Yogi government's former minister Om Prakash Rajbhar, he said that Rajbhar is not a controversial person. He is a big backward leader. He raises voice in favour of the backwards in the Assembly. He also supported us when I was in jail. We talked about how to stop the BJP and will take all necessary steps to prevent the BJP from coming back to power.

When asked why he had several run-ins with the police, Chandrashekhar said: "Ask this question to the police. Have I broken any law? Am I not a citizen of this country? There is no freedom of speech in the Yogi government. This is happening at the behest of the government. We are just opposing it".

Talking about the CAA, NRC and the NPR, he said: "We will not stage protest because the government does not want it. Any law which is wrong in our view will be opposed. This is a secular country. The CAA will divide the country. If there is anything against the Indian Constitution, we will raise our voice. Laws will not be allowed to be made on the basis of religion".

New Delhi, Jun 4: CSIR Director-General Shekhar Mande said on Thursday that the World Health Organisation's (WHO) decision to halt hydroxychloroquine (HCQ) drug trial was taken in haste and the global body should have actually analysed the data before making the decision.

"I firmly believe that WHO decision was taken in haste it was a kind of knee jerk reaction they should have actually analyse the data on their own before temporarily suspend the trials that is my personal opinion," Mande said.

India's nodal government agency ICMR (Indian Council of Medical Research) overseeing the country's response to the coronavirus pandemic last month wrote to the WHO citing differences in dosage standards between Indian and international trials that could explain the efficacy issues of HCQ in treating COVID-19 patients.

In addition, Dr Sheela Godbole, National Coordinator of the WHO-India Solidarity Trial and Head of the Division of Epidemiology, ICMR-National AIDS Research Institute also wrote a letter via an email to Dr Soumya Swaminathan, Chief Scientist at World Health Organisation.

In a letter, Dr Godbole stated: "There was no reason to suspend the trial for safety concern," attributing it to the current RECOVERY data which differs significantly from the non-randomised assessment by Mehra et al, a scientific paper.

Referring to the letter, the CSIR head said, "We don't know what actually happened behind the scenes but the hypothesis is that because of the paper published in Lancet. It is a very well known journal and if Lancet has done due vigilance in publishing the paper. 

Therefore, the WHO thought the paper's findings are right that's why WHO hold based on what is published on Lancet. The WHO shouldn't have accepted it immediately this should have taken their own due vigilance to find out that study is right or not."

DG CSIR said because there is a global outcry it must have put pressure on both Lancet as well as WHO and both of them now retracted from their original position. "WHO has started a trial again and Lancet has put an expression of concern on their website both of these are very welcome development for science," he said.

"So I am pretty sure that Lancet would have published the reports only after seeing somewhere the drug failed to work," Mande said.